Preoperative radiation may enhance treatment response in patients with HR-positive, H

[News]

Preoperative radiation improved T-cell infiltration (TCI) in patients with hormone receptor (HR)-positive, HER2-negative breast cancer when administered in combination with pembrolizumab (Keytruda) and chemotherapy and led to improved treatment responses prior to surgery, according to the results of the phase II P-RAD clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 9-12, 2025.

More... (https://www.news-medical.net/news/20251211/Preoperative-radiation-may-enhance-treatment-response-in-patients-with-HR-positive-HER2-negative-breast-cancer.aspx)